Pro-Dex (PDEX) Stock Price, News & Analysis

Company Overview

Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments and related accessories, with a focus on devices used in orthopedic procedures. Its products include surgical handpieces and drivers, along with the components and systems that support their operation.

The company also provides engineering, product development and manufacturing services to medical device companies. Its work can span the product lifecycle, from design and prototyping to production and servicing.

Founded in 1978, Pro-Dex is headquartered in Irvine, California, and serves customers in the United States and international markets.

Key Stats

• Today's Range: $64.81 to $69.66
• 50-Day Range: $57.65 to $73.41
• 52-Week Range: $28.81 to $77.00
• Volume: 22,793 shs
• Average Volume: 38,701 shs
• Market Capitalization: $210.11 million
• P/E Ratio: 17.99
• Dividend Yield: N/A
• Price Target: $74.00
• Consensus Rating: Moderate Buy

Pro-Dex Stock Analysis - MarketRank™

Pro-Dex scored higher than 54% of companies evaluated by MarketBeat, and ranked 492nd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Pro-Dex has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Pro-Dex has a consensus price target of $74.00, representing about 12.7% upside from its current price of $65.66.

Amount of Analyst Coverage

Pro-Dex has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.74%

Earnings Growth

Earnings for Pro-Dex are expected to grow by 8.74% in the coming year, from $3.09 to $3.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Pro-Dex is 17.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of Pro-Dex is 17.99, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.71.

Price to Book Value per Share Ratio

Pro-Dex has a P/B Ratio of 4.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.31% of the float of Pro-Dex has been sold short.

Short Interest Ratio / Days to Cover

Pro-Dex has a short interest ratio ("days to cover") of 7.42.

Change versus previous month

Short interest in Pro-Dex has recently increased by 15.01%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Pro-Dex does not currently pay a dividend.

Dividend Growth

Pro-Dex does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.13

News Sentiment

Pro-Dex has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Pro-Dex this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for PDEX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,351,657.00 in company stock.

Percentage Held by Insiders

48.00% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

15.28% of the stock of Pro-Dex is held by institutions.

Company Calendar

• Last Earnings: 10/29/2026
• Today: 11/14/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:PDEX
• CIK: 788920
• Web: www.pro-dex.com
• Phone: (949) 769-3200
• Fax: 949-769-3281
• Employees: 206
• Year Founded: 1975

Price Target and Rating

• Average Price Target for Pro-Dex: $74.00
• High Price Target: $74.00
• Low Price Target: $74.00
• Potential Upside/Downside: +12.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.65
• Trailing P/E Ratio: 17.99
• Forward P/E Ratio: 19.54
• P/E Growth: N/A
• Net Income: $13.66 million
• Net Margins: 15.12%
• Pretax Margin: 19.07%
• Return on Equity: 26.18%
• Return on Assets: 16.69%

Debt

• Debt-to-Equity Ratio: 0.25
• Current Ratio: 4.19
• Quick Ratio: 2.49

Sales & Book Value

• Annual Sales: $77.55 million
• Price / Sales: 2.71
• Cash Flow: $3.80 per share
• Price / Cash Flow: 17.27
• Book Value: $15.42 per share
• Price / Book: 4.26

Miscellaneous

• Outstanding Shares: 3,200,000
• Free Float: 1,664,000
• Market Cap: $210.11 million
• Optionable: Not Optionable
• Beta: 0.12